Inso Bio

Next generation DNA sample preparation

Inso Bio was founded in 2018, is headquartered in United States, lists 1–10 employees, and has $2.5M in recorded funding across 2 rounds.

Employees
1–10
Founded
2018
Website
inso.bio
Total Funding
$2.5M
Last Round
$2.2M Pre-SeedMar 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Inso Biosciences is a Cornell University-originated biotech company developing a microfluidic DNA sample preparation platform for next-generation sequencing. The company's patented 'micropillar' technology physically captures and purifies high molecular weight DNA directly from blood or cell samples in as little as 10 minutes, eliminating the degradation caused by conventional bead- or column-based approaches. The system enables ultra-long DNA fragment sizes (50 kb to 1,000+ kb), lossless RNA and DNA multiomic extractions, and automated workflows compatible with any downstream sequencer. Inso Biosciences is backed by NY Ventures and several academic and institutional investors.

Summary

Inso Bio is a Biotech company based in United States, founded in 2018. It lists 1–10 employees. It has raised $2.5M in total across 2 rounds, most recently a $2.2M Pre-Seed round in Mar 2022. Investors include 2048 Ventures.

Funding History

Pre-seedPre-SeedMar 2022
$2.2M

Sign up to see all 2 events

Funding: Grant through Pre-Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series ETotal funding$853.3MJun 2026
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Inso Bio on Indexed.vc
<a href="https://indexed.vc/companies/inso-bio"><img src="https://indexed.vc/api/badge/company/inso-bio" alt="Inso Bio on Indexed.vc" width="260" height="76" /></a>